01/23/2026
https://www.facebook.com/share/1BMdqCHAD1/?mibextid=wwXIfr
New approach to cancer treatment is showing promise by harnessing the body’s own immune system to target and destroy malignant tumors. Dr. Patrick Soon-Shiong is developing a therapy designed to activate and amplify immune cells, enabling them to recognize cancerous cells more effectively. This method could complement or even replace traditional chemotherapy, reducing the collateral damage and side effects often associated with standard cancer treatments.
Scientists explain that the therapy focuses on training immune cells to identify tumor-specific markers, strengthening the natural defense mechanisms that fight abnormal growth. Early laboratory and preclinical results indicate that immune activation can slow tumor progression, trigger cell death in malignant tissue, and potentially prevent recurrence. By using the body’s own defenses, the treatment minimizes harm to healthy cells, which is a major advantage over conventional therapies.
Experts caution that while these findings are encouraging, clinical trials are still needed to confirm safety, dosing, and long-term effectiveness in humans. Translating immune-based therapies into routine care requires careful monitoring and regulatory approval. Nevertheless, this research highlights a significant step toward more precise, less invasive cancer treatment, offering hope for improved outcomes and reduced reliance on chemotherapy in the future.
